EVALUATION of PREVENTIVE EFFECT of SEALANTS and LASER THERAPY on DENTAL CARIES and POSTERUPTIVE BREAKDOWN on MOLARS AFFECTED with MOLAR INCISOR HYPOMINERALISATION (RANDOMIZED CLINICAL TRIAL)
Launched by ALEXANDRIA UNIVERSITY · Jan 25, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to help protect the back teeth (molars) of children aged 6 to 9 who have a condition called Molar Incisor Hypomineralization (MIH). MIH affects the enamel, which is the hard outer layer of the teeth, making the molars more likely to develop cavities or break down after they come in. The researchers want to compare the effectiveness of a glass ionomer sealant and laser therapy in preventing dental problems in these teeth over 18 months.
To participate in this study, children must be between 6 and 9 years old and have at least one molar with MIH that does not already have any cavities or significant damage. Throughout the trial, the children will have their teeth checked at different times to see how well the treatments are working and whether they are experiencing any discomfort. This study is currently recruiting participants, and it's important for parents to know that the children selected will receive careful evaluations to ensure their overall health and eligibility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6-9 years old children (29)
- • One tooth with MIH with no PEB according to evaluation criteria proposed by Ghanim (2017) (APPENDIX I) (30) and ICDAS scores 0, 1 and 2 (APPENDIX II) (31)
- • Good overall health (ASA I) (APPENDIX III) (32)
- Exclusion Criteria:
- • First permanent molars with active carious lesions with ICDAS scores 5 and 6 (Appendix II) or defective restorations (31)
- • Sufficient dentin loss that requires restorative therapy
- • Any clinical signs of failure (abscess, fistula)
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported